| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 307,929 | 300,250 | 244,206 | 254,372 | | Cost of Revenue | 142,897 | 138,421 | 114,027 | 115,947 | | | Gross Profit | 165,032 | 161,829 | 130,179 | 138,425 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 72,117 | 69,046 | 64,402 | 177,643 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 92,915 | 92,783 | 65,777 | (39,218) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,759) | 402 | (2,523) | 1,380 | | Earnings Before Interest And Taxes | 92,755 | 93,185 | 63,254 | (37,838) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 92,755 | 93,185 | 63,254 | (37,838) | | Income Tax Expense | 36,251 | 35,895 | 21,689 | (14,390) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 56,504 | 57,290 | 41,565 | (23,448) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 56,504 | 57,290 | 41,565 | (23,448) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $56,504 | $57,290 | $41,565 | ($23,448) |
|
1.00% Nasdaq 0.00%
Income Statement
